Targeting these alongside obesity allows for separate reimbursement channels vs
All authors contributed to the article and approved the submitted version
Activity modification during the healing phase allows tissue repair without constant re-injury
Once in the bloodstream, cibinetide binds this receptor on immune cells (especially myeloid cells like macrophages and microglia), endothelial cells, and other stressed tissues, triggering intracellular signaling (e.g., JAK/STAT, PI3K/Akt, and inhibition of NF-B p65) that dampens innate immune overactivation, suppresses production and systemic release of pro-inflammatory cytokines (TNF-, IL-1, IL-6, IL-12/IL-23), reduces chemokine-driven cell infiltration, lowers oxidative stress and nitric oxide overproduction, and promotes anti-inflammatory shifts and cell survival